Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00006384 · ClinicalTrials.gov registry record · Phase 2

SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

A Phase 2 study of Kidney Cancer, sponsored by City of Hope Medical Center.

Completed
Registry status
Phase 2
Development phase
3
Study locations

NCT00006384 is a Phase 2 study of Kidney Cancer that has completed, run by City of Hope Medical Center. The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00006384, a Phase 2 study of Kidney Cancer, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
3
Study locations

Study Summary

RATIONALE: SU5416 may stop the growth of kidney cancer by stopping blood flow to the tumor. Interferon alfa-2b may interfere with the growth of the cancer cells. Combining interferon alfa-2b with SU5416 may be an effective treatment for kidney cancer. PURPOSE: Phase II trial to study the effectiveness of combining SU5416 and interferon alfa-2b in treating patients who have unresectable or metastatic kidney cancer.

Conditions Studied

Kidney Cancer

Interventions

  • BIOLOGICAL recombinant interferon alfa
  • DRUG semaxanib

Study Locations (3)

California

  • Cancer Center and Beckman Research Institute, City of Hope - Duarte
  • USC/Norris Comprehensive Cancer Center and Hospital - Los Angeles
  • University of California Davis Cancer Center - Sacramento

Trial Details

FieldValue
Start Date 2000-11
Est. Completion 2007-02
Phase Phase 2

Sponsor

City of Hope Medical Center

582 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00006384

The ClinicalTrials.gov registry entry for NCT00006384 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Cancer appearing as the primary indexed condition, and to 2 interventions - of which recombinant interferon alfa is the first listed.

NCT00006384 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00006384 about?

NCT00006384 is a clinical study titled "SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer". RATIONALE: SU5416 may stop the growth of kidney cancer by stopping blood flow to the tumor. Interferon alfa-2b may interfere with the growth of the cancer cells. Combining interferon alfa-2b with SU5416 may be an effective treatment for kidney cancer. PURPOSE: Phase II trial to study the effectiven...

What is the current status of trial NCT00006384?

This trial is currently completed. It is a Phase 2 study. The study started on 2000-11. Estimated completion is 2007-02.

What conditions does trial NCT00006384 study?

This clinical trial studies the following conditions: Kidney Cancer.

What interventions are being tested in trial NCT00006384?

The interventions under investigation include: recombinant interferon alfa (BIOLOGICAL), semaxanib (DRUG).

Who is sponsoring clinical trial NCT00006384?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00006384 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.